Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid YouGov (YOU) by Steve Moore in ShareProphets
- Avoid Warpaint London (W7L) by Steve Moore in ShareProphets
- Buy Vodafone Group (VOD) by DZ Bank
- Watch Mony Group (MONY) by Simon Watkins in The Motley Fool
- Add BP (BP.) by Andrew Mackie in The Motley Fool
- Buy Taylor Wimpey (TW.) by Simon Watkins in The Motley Fool
- Reduce Safestore Holdings (SAFE) by Kepler Cheuvreux
- Add S&U (SUS) by Peel Hunt
- Buy Mitchells & Butlers (MAB) by Deutsche Bank
- Sell Croda International (CRDA) by Goldman Sachs
- Neutral Rio Tinto (RIO) by UBS
- Neutral Rio Tinto (RIO) by Citi
- Buy Antofagasta (ANTO) by Citi
- Buy Glencore (GLEN) by Citi
- Neutral LondonMetric Property (LMP) by Goldman Sachs
- Neutral Drax Group (DRX) by Goldman Sachs
- Outperform Serco Group (SRP) by RBC Capital
- Equal Weight Safestore Holdings (SAFE) by Barclays
- Overweight Big Yellow Group (BYG) by Barclays
- Buy Legal & General Group (LGEN) by Berenberg
SkinBioTherapeutics (SBTX) Share Price
Health Care Sector
NOTE: This is based on 50 open tips for SkinBioTherapeutics (SBTX)
| Latest Bid : 19.50p | Latest Ask : 20.00p |
| High Today : 20.00p | Low Today : 19.50p |
| This Years High : 26.10p | This Years Low : 12.25p |
| Volume : 572,889 | MKT Cap : £45.03M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
SkinBioTherapeutics (SBTX) Overview
SkinBioTherapeutics is a life science company focused on skin health. The Company's proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O'Neill and Professor Andrew McBain at The University of Manchester.SkinBioTherapeutics (SBTX) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Tom Winnifrith | Premium Only | 2025-04-19 12:30:00 19/04/2025 | -7.06% |
| Strong Buy | Tom Winnifrith | Premium Only | 2025-04-17 08:55:00 17/04/2025 | -5.95% |
| Hold | Hot Stock Rockets | Premium Only | 2025-03-27 14:00:00 27/03/2025 | -19.39% |
| Buy | Hot Stock Rockets | Premium Only | 2025-02-25 15:00:00 25/02/2025 | -3.66% |
| Buy | Hot Stock Rockets | Premium Only | 2024-12-06 09:30:00 06/12/2024 | 19.70% |
SkinBioTherapeutics (SBTX) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 19.50p | Latest Ask : 20.00p |
| High Today : 20.00p | Low Today : 19.50p |
| This Years High : 26.10p | This Years Low : 12.25p |
| Volume : 572,889 | MKT Cap : £45.03M |
SkinBioTherapeutics Overview
SkinBioTherapeutics is a life science company focused on skin health. The Company's proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O'Neill and Professor Andrew McBain at The University of Manchester.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest SkinBioTherapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Tom Winnifrith | Premium Only | 2025-04-19 12:30:00 19/04/2025 | -7.06% |
| Strong Buy | Tom Winnifrith | Premium Only | 2025-04-17 08:55:00 17/04/2025 | -5.95% |
| Hold | Hot Stock Rockets | Premium Only | 2025-03-27 14:00:00 27/03/2025 | -19.39% |
| Buy | Hot Stock Rockets | Premium Only | 2025-02-25 15:00:00 25/02/2025 | -3.66% |
| Buy | Hot Stock Rockets | Premium Only | 2024-12-06 09:30:00 06/12/2024 | 19.70% |